Kinnjiu Biopharma

Kinnjiu Biopharma

Private
United KingdomFinTechhttps://www.cloudpay.com

Last Round

Series G

Aug 8, 2024

Est. Valuation

$290M

Total Funding Raised

$340.45M

Company Overview

Kinnjiu Biopharma is a biopharmaceutical company focused on developing innovative drug treatments for solid tumors, including melanoma and lung cancer.

Sector

FinTech

Verticals

HR, Digital Payments, Compliance, Workflow Automation, Accounting & Expense

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Payment Processing Fee

AI Layer

Non-AI

Keywords

global payrollmanaged payroll servicespayroll platformpayroll outsourcingmulti-country payrollglobal paymentsearned wage accessEWApay on-demandpayroll compliancecross-border paymentsWorkday integrationHCM integrationpayroll automationtreasury servicesPEPM billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kinnjiu Biopharma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kinnjiu Biopharma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series GAug 8, 2024
Follow-on OfferingOct 27, 2022
Series DAug 17, 2021
Growth EquityAug 4, 2020
Series CMay 3, 2018
Series B
Dec 5, 2012

Kinnjiu Biopharma Investors

Notable investors and investment history

InvestorRounds
Owl Rock Capital GroupSeries G
Runway Growth CapitalFollow-on Offering, Growth Equity
Hercules CapitalSeries C
Rho VenturesGrowth Equity, Debt, Series B, Series C, Series A
Blue Owl CapitalSeries G
The Olayan GroupSeries G, Series D, Follow-on Offering
Rho Capital PartnersSeries G, Series B, Series C, Growth Equity, Series D, Debt, Series A

Kinnjiu Biopharma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kinnjiu Biopharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kinnjiu Biopharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited Kingdom
Year Founded1996
Last FundingAug 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.